Pages that link to "Q37320347"
Jump to navigation
Jump to search
The following pages link to Drugs used to treat Parkinson's disease, present status and future directions. (Q37320347):
Displaying 16 items.
- Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases (Q27675992) (← links)
- Glial modulators as potential treatments of psychostimulant abuse (Q28307030) (← links)
- An in vivo microdialysis study of FLZ penetration through the blood-brain barrier in normal and 6-hydroxydopamine induced Parkinson's disease model rats (Q33876743) (← links)
- A mitocentric view of Alzheimer's disease suggests multi-faceted treatments (Q34902708) (← links)
- Paeonolum protects against MPP(+)-induced neurotoxicity in zebrafish and PC12 cells (Q35577339) (← links)
- Treating non-motor symptoms of Parkinson's disease with transplantation of stem cells (Q36790753) (← links)
- Minocycline: far beyond an antibiotic (Q36836358) (← links)
- Glutathione metabolism and Parkinson's disease (Q37078480) (← links)
- The role of phytochemicals in the treatment and prevention of dementia (Q37884566) (← links)
- Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid-induced Parkinson's disease in mice (Q41524210) (← links)
- Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists. (Q46279808) (← links)
- Antiparkinsonian Effects of Aqueous Methanolic Extract of Hyoscyamus niger Seeds Result From its Monoamine Oxidase Inhibitory and Hydroxyl Radical Scavenging Potency (Q46299714) (← links)
- Do adipose tissue-derived mesenchymal stem cells ameliorate Parkinson's disease in rat model? (Q46332910) (← links)
- Minocycline Protects Against NLRP3 Inflammasome-Induced Inflammation and P53-Associated Apoptosis in Early Brain Injury After Subarachnoid Hemorrhage (Q46705153) (← links)
- Cytoprotective activity of minocycline includes improvement of mitochondrial coupling: the importance of minocycline concentration and the presence of VDAC. (Q47780137) (← links)
- Increases in β-amyloid protein in the hippocampus caused by diabetic metabolic disorder are blocked by minocycline through inhibition of NF-κB pathway activation. (Q51007701) (← links)